Moreover, multiple CNAs recurrently featured in ATRX-deficient glioma mobilize established oncogenic and/or tumor suppressive loci, including MYC and CDKN2A2, implying that such structural abnormalities may contribute to the malignant evolution of this inexorably progressive cancer. The gene discussed is ATRX; the disease is central nervous system cancer.